TCMBANKIN000023 |
acetyl-11-keto-β-boswellicacid |
acetyl 11-keto-β-boswellic acid |
C32H48O5 |
|
|
TCMBANKIN000064 |
diosgenin |
AKOS025402315; MolPort-028-744-580; (25R)-5-Spirosten-3beta-ol; 3beta-Hydroxy-5-spirostene; nitogenin; NSC 226132; Spirost-5-en-3-ol, (3beta,25S)-; diosgenin ; AC-8024; 512-04-9; 22-epi-Yamogenin; C08898; D1634_SIGMA |
C27H42O3 |
414.62 |
CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)O)C)C)C)OC1 |
TCMBANKIN000065 |
dioscin |
LMST01080053; C08897; 3-O-(Rhaa1-4(Rhaa1-2)Glcb)-(25R)-spirost-5-en-3beta-ol; dioscin ; 19057-60-4; Dioscin |
C45H72O16 |
869.04 |
CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)OC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)C)O)O)O)O)OC9C(C(C(C(O9)C)O)O)O)C)C)C)OC1 |
TCMBANKIN000269 |
Original new Dioscin |
|
|
|
|
TCMBANKIN001009 |
protogracillin_qt |
|
C51H84O23 |
1065.2 |
|
TCMBANKIN001941 |
Methyl original slim new saponins |
|
|
|
|
TCMBANKIN002744 |
Pregn gestodene-3-O-β-Potato three glycoside |
|
|
|
|
TCMBANKIN003208 |
(12Z,15Z)-9,10,11-Trihydroxy-12,15- Octadecadienoic acid |
|
C18H32O5 |
|
CCC=CCC=CC(C(C(CCCCCCCC(=O)O)O)O)O |
TCMBANKIN003525 |
dioseptemloside I |
|
|
|
|
TCMBANKIN004010 |
polysaccharide ii |
|
|
|
|
TCMBANKIN004040 |
myrtenic acid |
Myrtenate; myrtenicacid; 6,6-Dimethyl-2-norpinene-2-carboxylate; 6,6-Dimethylbicyclo[3.1.1]hept-2-ene-2-carboxylate |
C14H28O2 |
228.37 |
CC1(C2CC=C(C1C2)C(=O)[O-])C |
TCMBANKIN004829 |
dioseptemloside A |
|
C45H74O18 |
903.1 g/mol |
CC1C(C(C(C(O1)OC2C(OC(C(C2O)O)OC3CCC4(C5CC(=O)C6(C(C5CC=C4C3)CC(C6C(C)C(CCC(C)C)O)OC7C(C(C(C(O7)CO)O)O)O)C)C)CO)O)O)O |
TCMBANKIN004892 |
3,7-Dimethyl-6-Octene-1-ol ester |
|
|
|
|
TCMBANKIN005237 |
(R)-1-Octen-3-ol-O-α-L- arabinopyranosyl-(1 → 6)-β-D- glucopyranoside |
|
|
|
|
TCMBANKIN006777 |
menthiafolin |
[5-ethenyl-4a,5-dimethyl-1-oxo-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,6-dihydro-3H-pyrano[3,4-c]pyran-3-yl] (2E)-6-hydroxy-2,6-dimethylocta-2,7-dienoate; AC1NSXZ4 |
C26H36O12 |
540.6 g/mol |
CC(=CCCC(C)(C=C)O)C(=O)OC1CC2C(C(OC=C2C(=O)O1)OC3C(C(C(C(O3)CO)O)O)O)C=C |
TCMBANKIN007035 |
Stingless date emetic glycosides I |
|
|
|
|
TCMBANKIN007076 |
amaroid |
|
|
|
|
TCMBANKIN007258 |
Yamogenin |
WQLVFSAGQJTQCK-CAKNJAFZSA-N; (25S)-spirost-5-en-3beta-ol; NSC 226132; LMST01080045; AC1L9BVW; AC-8895; S00020; (2R,5'S)-5'-tetramethylspiro[[?]-2,2'-tetrahydropyran]ol; Jamogenin; Neodiosgenin; AKOS025402417; CHEBI:10086; Spirost-5-en-3-ol, (3beta,25S)-; SCHEMBL6040875; CHEMBL400807; C08918; yamogenin; ZINC8234229; 512-06-1; 25-epi-Diosgenin |
C27H42O3 |
414.62 |
CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)O)C)C)C)OC1 |
TCMBANKIN007442 |
p-menth-4-en-3-one |
AN-19961; 5-Methyl-2-(1-methylethyl)-2-cyclohexen-1-one; 2-isopropyl-5-methyl-cyclohex-2-en-1-one; 5-methyl-2-propan-2-ylcyclohex-2-en-1-one; 2-Isopropyl-5-methyl-2-cyclohexen-1-one #; p-Menth-4-en-3-one; AC1L321A; 5-methyl-2-propan-2-yl-cyclohex-2-en-1-one; 5-methyl-2-isopropyl-2-cyclohexen1-one; SCHEMBL6360973; 2-isopropyl-5-methylcyclohex-2-enone; OAYBZGPDRAMDNF-UHFFFAOYSA-N; AC1Q6CEV; CTK1H2606; 5113-66-6; 2-Cyclohexen-1-one, 5-methyl-2-(1-methylethyl)- |
C10H16O |
152.23 |
CC1CC=C(C(=O)C1)C(C)C |
TCMBANKIN008305 |
(+)-3-α-hydroxylupanine |
|
|
|
|
TCMBANKIN008694 |
dioscoresides C |
|
|
|
|
TCMBANKIN009718 |
Methyl former New Dioscin |
|
|
|
|
TCMBANKIN009784 |
Dioscorea hypoglauca palibin F |
|
|
|
|
TCMBANKIN010599 |
EINECS 213-897-0 |
(20R,25R)-Spirost-5-en-3beta-yl acetate |
C29H44O4 |
456.7 g/mol |
CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)OC(=O)C)C)C)C)OC1 |
TCMBANKIN011887 |
1-octene-yn-4-ol |
|
C8H12O |
|
CC=CC#CCCCO |
TCMBANKIN012682 |
Pepper alcohol |
|
|
|
|
TCMBANKIN013396 |
dioseptemloside B |
|
C33H54O9 |
594.8 g/mol |
CC(C)CCC(C(C)C1C(CC2C1(C(=O)CC3C2CC=C4C3(CCC(C4)O)C)C)OC5C(C(C(C(O5)CO)O)O)O)O |
TCMBANKIN013439 |
insensole oxide |
|
|
|
CC1=CCCC2(C(O2)CC3(CCC(O3)(C(CC1)O)C)C(C)C)C |
TCMBANKIN013916 |
Deoxyvasicinone |
Pyrrolo(2,1-b)quinazolin-9(1H)-one, 2,3-dihydro-; 1,2,3,10-tetrahydro-pyrrolo[2,1-b]quinazolin-9-one; AC1Q1HJF; BG00602365; BBL028460; InChI=1/C11H10N2O/c14-11-8-4-1-2-5-9(8)12-10-6-3-7-13(10)11/h1-2,4-5H,3,6-7H; AC1Q6FYI; ST50135008; 1H,2H,3H,9H-pyrrolo[2,1-b]quinazolin-9-one; SCHEMBL864139; 4-hydropyrrolidino[2,1-b]quinazolin-5-one; AKOS002210198; VARHXCYGZKSOOO-UHFFFAOYSA-N; DTXSID90201049; deoxyvasicinone; W1018; STOCK1N-00997; cid_68261; Pyrrolo[2,1-b]quinazolin-9(1H)-one, 2,3-dihydro-; MolPort-000-489-741; CHEBI:4435; 3H-Quinazolin-4-one, 2,3-trimethyleno; FCH831074; SR-01000434191; 2,3-dihydro-1H-pyrrolo[2,1-b]quinazolin-9-one\n2,3-dihydro-1H-pyrrolo[2,1-b]quinazolin-9-one\n2,3-Dihydro-1H-pyrrolo[2,1-b]quinazolin-9-one; BDBM50244216; SMR000024071; HMS2507B03; MLS000088451; MFCD00247051; STL373117; ZINC226366; NSC 159478; AC1L29DJ; BB_NC-02943; SR-01000434191-1; CHEMBL456881; NSC159478; ZINC00226366; 4CN-1561; MCULE-8877508828; NSC-159478; 530-53-0; BB_NC-1382; C10659; 2,3-Dihydro-1H-pyrrolo[2,1-b]quinazolin-9-one; Pyrrolo[2,1-b]quinazolin-9(1H)-one,2,3-dihydro-; Desoxyvasicinon; 2,3-Trimethylene-4-quinazolone; 2,3-dihydropyrrolo[2,1-b]quinazolin-9(1H)-one |
C11H10N2O |
186.21 |
C1CC2=NC3=CC=CC=C3C(=O)N2C1 |
TCMBANKIN014099 |
Δ3, 5- deoxy-new report for sapogenin |
|
|
|
|
TCMBANKIN014630 |
4,8-dimethyl-1,7-nonadiene |
|
C11H20 |
152.28 g/mol |
CC(CCC=C(C)C)CC=C |
TCMBANKIN014652 |
Sesame ketone |
|
|
|
|
TCMBANKIN014783 |
Original fine saponins |
|
|
|
|
TCMBANKIN014885 |
dioscoresides E |
|
C53H88O23 |
|
CCC1C(CC2C1(CCC3C2CC=C4C3(CCC(C4)OC5C(C(C(C(O5)CO)O)OC6C(C(C(C(O6)CO)O)O)O)OC7C(C(C(C(O7)C)O)O)O)C)C)OC(=C)C(CC(C)COC8C(C(C(C(O8)CO)O)O)O)OC |
TCMBANKIN015484 |
dioscorone A |
|
C19H22N4O9 |
|
CC1=CC(=O)OC2(C1)CC3CCC2CN3C.C1=C(C=C(C(=C1[N+](=O)[O-])O)[N+](=O)[O-])[N+](=O)[O-] |
TCMBANKIN016655 |
dioseptemloside J |
|
|
|
|
TCMBANKIN017014 |
20-ketone-5,16-Diene-Methoxy-3β-O-α-L-Rhamnopyranosyl-(1→2)-O-[α-L-Rhamnopyranosyl-(1→4)]-β-D-Glucopyranoside |
|
|
|
|
TCMBANKIN017298 |
Methyl original slim saponins |
|
|
|
|
TCMBANKIN017647 |
Dioscoreae Spongiosae Rhizoma glycoside A |
|
|
|
|
TCMBANKIN017809 |
Dioscorea septemloba Thunb steroidal saponins B |
|
|
|
|
TCMBANKIN019866 |
Dioscoreae Spongiosae Rhizoma glycoside B |
|
|
|
|
TCMBANKIN020121 |
bassorin |
|
|
|
CC(C)NC1=NC(=NC(=N1)N=[N+]=[N-])SC |
TCMBANKIN021994 |
Dioscorea septemloba Thunb steroidal saponins A |
|
|
|
|
TCMBANKIN022657 |
Dioscorea septemloba Thunb steroidal saponins C |
|
|
|
|
TCMBANKIN022673 |
Δ3,5- deoxy-sue for sapogenin |
|
|
|
|
TCMBANKIN023033 |
Lu Marcus sapogenin |
|
|
|
|
TCMBANKIN023405 |
Dioscorea septemloba Thunb steroidal saponins D |
|
|
|
|
TCMBANKIN023901 |
α-boswellicacid |
CTK8G3918; DTXSID60590811; α-boswellic acid; I07-0238; alpha-boswellic acid; AKOS015896778; (5xi,9xi,10xi)-3-Hydroxyolean-12-en-23-oic acid; AN-45134; 471-66-9; (6aR,6bS,8aR,12aR)-3-hydroxy-4,6a,6b,8a,11,11,14b-heptamethyl-1,2,3,4a,5,6,7,8,9,10,12,12a,14,14a-tetradecahydropicene-4-carboxylic acid |
C30H48O3 |
456.7 g/mol |
CC1(CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C(=O)O)O)C)C)C2C1)C)C)C |
TCMBANKIN024287 |
glycoside D |
|
C45H74O18 |
903.1 g/mol |
CC1C2C(CC3C2(CCC4C3CC=C5C4(CCC(C5)OC6C(C(C(C(O6)CO)O)O)OC7C(C(C(C(O7)C)O)O)O)C)C)OC1(CCC(C)COC8C(C(C(C(O8)CO)O)O)O)O |
TCMBANKIN025421 |
Dioscorea hypoglauca palibin G |
|
|
|
|
TCMBANKIN025483 |
(12Z)-9,10,11-Trihydroxy-octadecadienoic acid |
|
C18H34O5 |
|
CCCCCC=CC(C(C(CCCCCCCC(=O)O)O)O)O |
TCMBANKIN025827 |
3-phenyl-6,8-Dihydroxy-dihydro-iso-coumarin |
|
|
|
|
TCMBANKIN026590 |
Diosgenin acetate |
AC1Q5X0O; diosgenin acetate |
C29H44O4 |
456.7 g/mol |
CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)OC(=O)C)C)C)C)OC1 |
TCMBANKIN027076 |
methylprotodioscin |
CHEMBL1993106; NCI60_035342; methyl protodioscin; NSC-698790; Methyl protodioscin; NSC698790 |
C52H86O22 |
1063.23 |
CC1C2C(CC3C2(CCC4C3CC=C5C4(CCC(C5)OC6C(C(C(C(O6)CO)OC7C(C(C(C(O7)C)O)O)O)O)OC8C(C(C(C(O8)C)O)O)O)C)C)OC1(CCC(C)COC9C(C(C(C(O9)CO)O)O)O)OC |
TCMBANKIN027287 |
polysaccharide i |
|
|
|
|
TCMBANKIN027516 |
N, N'- disuccinic nitro-1,2-cyclohexanediamine |
|
|
|
|
TCMBANKIN028241 |
Twelve Methyl |
|
|
|
|
TCMBANKIN028893 |
viridifloro |
|
|
|
|
TCMBANKIN029726 |
20-ketone-5-Diene-16-Methoxy-3β-O-α-L-Rhamnopyranosyl-(1→2)-O-[α-L-Rhamnopyranosyl-(1→4)]-β-D-Glucopyranoside |
|
|
|
|
TCMBANKIN029963 |
Original new slim saponins |
|
|
|
|
TCMBANKIN030393 |
3,6,6-trimethylundecyl-2,5,10-trione |
|
|
239.37 |
|
TCMBANKIN031333 |
Pseudo-original slim saponins |
|
|
|
|
TCMBANKIN031915 |
insensole |
|
|
|
|
TCMBANKIN032466 |
5-isopropyl-2-methylbicyclo[3.1.0]hex-2-ene |
(5R)-4-methyl-1-propan-2-yl-bicyclo[3.1.0]hex-3-ene; (5R)-1-isopropyl-4-methyl-bicyclo[3.1.0]hex-3-ene; InChI=1/C10H16/c1-7(2)10-5-4-8(3)9(10)6-10/h4,7,9H,5-6H2,1-3H; (5R)-1-isopropyl-4-methylbicyclo[3.1.0]hex-3-ene; (5R)-4-methyl-1-propan-2-ylbicyclo[3.1.0]hex-3-ene |
C10H16 |
136.23 |
CC1=CCC2(C1C2)C(C)C |
TCMBANKIN033626 |
lup-20(29)-ene-3α-acetoxy-24-oicacid |
|
|
|
|
TCMBANKIN033865 |
dioscoreside F |
|
|
|
|
TCMBANKIN034799 |
arabic acid |
D-Arabonic acid; 2E716807-8A6D-4F87-9367-F672358A801B; D-Arabonate; 4-03-00-01205 (Beilstein Handbook Reference); NCIOpen2_000178; ARABINIC ACID; AC1Q5SR9; J98.583J; SCHEMBL595388; BRN 1724262; CHEBI:6268; D-D-Arabonate; LS-21521; ARABINONIC ACID, D-; AC1L1UTZ; 2,3,4,5-tetrahydroxypentanoic acid; bmse000166; ARABONIC ACID, K SALT; pentonic acid |
C5H10O6 |
166.13 g/mol |
C(C(C(C(C(=O)O)O)O)O)O |
TCMBANKIN035452 |
olibanore-sene |
|
|
|
|
TCMBANKIN036302 |
6 /7-hydroxyferruginol |
|
|
|
|
TCMBANKIN036350 |
1-acetyl-4-isopropenylcyclopentene |
1-acetyl-4-isopropenyl cyclopentene |
C10H14O |
150.22 |
CC(=C)C1CC=C(C1)C(=O)C |
TCMBANKIN036814 |
β-Amyrin |
SCHEMBL14226156; beta-Amyrine; β- amyrin; beta-amyrin ; beta-amyrin; 12-oleanex-3beta-ol; NSC-527971 |
|
426.72 |
|
TCMBANKIN036865 |
gracillin |
CCRIS 4124; 19083-00-2; beta-D-Glucopyranoside, (3beta,25R)-spirost-5-en-3-yl O-6-deoxy-alpha-L-mannopyranosyl-(1-2)-O-(beta-D-glucopyranosyl-(1-3))-; NSC 698787; C08901; gracillin |
C48H78O16 |
911 |
C1([H])([H])C([H])([H])[C@@]2(C([H])([H])[H])C(=C([H])C([H])([H])[C@]3([H])[C@]2([H])C([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]4([H])[C@]([H])(O[C@]5(C([H])([H])C([H])([H])[C@@]([H])(C([H])([H])
[H])C([H])([H])O5)[C@@]4([H])C([H])([H])[H])C6([H])[H])[C@@]36[H])C([H])([H])[C@@]1([H])OOC([H])([H])[C@@]([H])(C([H])([H])[C@@]([H])(C([H])([H])O[H])[C@]7([H])O[C@@]([H])(O[C@]([H])(C([H])([H])[H])[C
@]8([H])O[H])[C@@]([H])(O[H])[C@]8([H])O[H])[C@@]([H])(C([H])([H])O[C@@]([H])(O[C@]([H])(C([H])([H])[H])[C@]9([H])O[H])[C@@]([H])(O[H])[C@]9([H])O[H])[C@]7([H])O[H] |
TCMBANKIN036926 |
dioseptemloside h |
|
C42H68O13 |
781 |
C1([H])([H])C([H])([H])[C@@]2(C([H])([H])[H])C(=C([H])[C@@]([H])(C([H])(C([H])([H])[H])C([H])([H])[H])[C@]3([H])[C@]2([H])C([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])([C@]([H])(C([H])([H])[H]
)[C@@]4(C([H])([H])C([H])([H])[C@](C([H])([H])[H])(O[H])C([H])([H])O4)O5)[C@]5([H])C6([H])[H])[C@]36[H])C([H])([H])[C@@]1([H])O[C@]([H])(O[C@]([H])(C([H])([H])O[H])[C@@]7([H])O[C@]([H])(O[C@@]8([H])C(
[H])([H])[H])[C@]([H])(O[H])[C@]([H])(O[H])[C@@]8([H])O[H])[C@]([H])(O[H])[C@]7([H])O[H] |
TCMBANKIN036993 |
Pseudoprotodioscin |
Pseudo protodioscin |
|
1031.18 |
|
TCMBANKIN037083 |
octyl acetate |
(2S)-2-Ethylhexyl acetate; (2S)-2-Ethylhexyl acetic acid; ZINC1648315; UNII-2C7K8OA8SB component WOYWLLHHWAMFCB-JTQLQIEISA-N; SCHEMBL14625765; octylacetate; AJ-28755; Acetic acid (S)-2-ethylhexyl ester; CJ-05947; CJ-26671; CHEBI:88553 |
C10H20O2 |
172.265 |
C(OC([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H])(=O)C([H])([H])[H] |
TCMBANKIN037349 |
Dumoside |
|
|
798.9 g/mol |
|
TCMBANKIN038488 |
Protogracillin |
p-rotogracillin |
|
1065.2 |
|
TCMBANKIN038707 |
alpha-amyrin |
α-Amyrin; C08615; Urs-12-en-3-ol; Urs-12-en-3-ol, (3beta)- (9CI); alpha-Amyrine; Urs-12-en-3.beta.-ol; ST5411384; (3S,4aR,6aR,6bS,8aR,11R,12S,12aR,14aR,14bR)-4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1H-picen-3-ol; (3S,4aR,6aR,6bS,8aR,11R,12S,12aR,14aR,14bR)-4,4,6a,6b,8a,11,12,14b-Octamethyl-1,2,3,4,4a,5,6,6a,6b,7,8,8a,9,10,11,12,12a,14,14a,14b-eicosahydro-picen-3-ol; (3.beta.)-Urs-12-en-3-ol; 3-epi-α-amyrin; A834570; Urs-12-en-3-ol #; FSLPMRQHCOLESF-UHFFFAOYSA-N; EINECS 211-352-1; MCULE-7089035597; 12-ursen-3beta-ol; .alpha.-Amyrine; α-amyrin; NSC-114787; alpha-Amyrin; AC1L5E7U; Urs-12-en-3beta-ol; alpha-Amyrenol; Viminalol; 638-95-9; AIDS-070313; Epi-alpha-amyrin; 53017_FLUKA; AIDS070313; AC1Q7B25; .alpha.-Amyrin; 4,4,6a,6b,8a,11,12,14b-octamethyl-2,3,4a,5,6,7,8,9,10,11,12,12a,14,14a-tetradecahydro-1H-picen-3-ol; NSC 114787; NSC114787; alpha-amyrin ; Urs-12-en-3-ol, (3.beta.)-; .alpha.-Amyrenol; LMPR01060011; α- amyrin; SMP2_000308 |
C30H50O |
426.72 |
CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1C)C)C |
TCMBANKIN039768 |
dioseptemloside G |
|
C46H74O18 |
915.1 g/mol |
CC1C2C(CC3C2(CCC4C3C(C=C5C4(CCC(C5)OC6C(C(C(C(O6)CO)OC7C(C(C(C(O7)C)O)O)O)O)OC8C(C(C(C(O8)C)O)O)O)C)O)C)OC19CCC(CO9)(C)CO |
TCMBANKIN040186 |
11-keto-α-amyrenone |
|
C30H46O2 |
438.76 |
CC1CCC2(CCC3(C(=CC(=O)C4C3(CCC5C4(CCC(=O)C5(C)C)C)C)C2C1C)C)C |
TCMBANKIN040381 |
dioseptemloside D |
|
C40H64O14 |
768.9 g/mol |
CC1C2C(CC3C2(CCC4C3C(C=C5C4(CCC(C5)OC6C(C(C(C(O6)CO)OC7C(C(C(C(O7)C)O)O)O)O)O)C)O)C)OC18CCC(CO8)(C)CO |
TCMBANKIN041630 |
Nopinone |
(+)-Nopinone; (1R,5S)-6,6-Dimethylbicyclo[3.1.1]heptan-2-one; CJ-29243; (1R,5S)-6,6-dimethyl-Bicyclo[3.1.1]heptan-2-one; (1R)-(+)-Nopinone; AK116367; MolPort-027-835-982; SCHEMBL2388827; 38651-65-9; J-500368; AJ-31006; ZINC1721658; KB-00407; MFCD08447116; Bicyclo[3.1.1]heptan-2-one, 6,6-dimethyl-, (1R,5S)-; Norinone; BG01196965; (1R)-(+)-Nopinone, 98%; AKOS016010310; CHEMBL3782017; XZFDKWMYCUEKSS-BQBZGAKWSA-N; BG01497854 |
|
138.21 g/mol |
|
TCMBANKIN043656 |
dioseptemloside e |
|
C48H78O16 |
911 |
[C@]1([H])(C([H])([H])[H])O[C@@]([H])(O[C@]2([H])[C@@]([H])(C([H])([H])O[H])O[C@@]([H])(C([H])([H])[C@@]([H])(C([H])([H])C([H])([H])[C@@]3(C([H])([H])[H])C4=C([H])[C@@]([H])(C([H])(O[H])[H])[C@]5([H])
[C@]3([H])C([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@]([C@]([H])(C([H])([H])[H])[C@@]6(C([H])([H])C([H])([H])[C@](C([H])([H])[H])([H])C([H])([H])O6)O7)([H])[C@]7([H])C8([H])[H])[C@]58[H])C4([H])[H]
)[C@]([H])(O[C@](C([H])([H])[H])(O[C@]9([H])C([H])([H])[H])[C@@]([H])(O[H])[C@@]([H])(O[H])[C@]9([H])O[H])[C@@]2([H])O[H])[C@]([H])(O[H])[C@]([H])(O[H])[C@@]1([H])O[H] |
TCMBANKIN043830 |
b-methylaseculetin |
|
|
192.168 |
CC1=CC(=O)OC2=CC(=C(C=C12)O)O |
TCMBANKIN044143 |
dioseptemloside F |
|
C39H62O13 |
738.9 g/mol |
CC1CCC2(C(C3C(O2)CC4C3(CCC5C4C(C=C6C5(CCC(C6)OC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)C)O)O)O)O)O)C)O)C)C)OC1 |
TCMBANKIN044769 |
Phellandral |
EINECS 244-355-1; 21391-98-0; 4-propan-2-ylcyclohexene-1-carbaldehyde; 4-(propan-2-yl)cyclohex-1-ene-1-carbaldehyde; 4-isopropylcyclohex-1-enecarbaldehyde; SCHEMBL220029; 4-ISOPROPYLCYCLOHEX-1-ENE-1-CARBALDEHYDE; 4-isopropylcyclohexen-1-aldehyde; ACMC-20lync; AC1L3HZ6; AC1Q6A4A; p-menth-1-en-7-al; AKOS022634915; Phellandral; 4-Isopropylcyclohexenecarbaldehyde; (S)-Phellandral; 1-Cyclohexene-1-carboxaldehyde, 4-(1-methylethyl)-, (R)-; 1-Cyclohexene-1-carboxaldehyde, 4-(1-methylethyl)-; 4-[1-Methylethyl]-1-cyclohexene-1-carboxaldehyde; 4-Isopropyl-1-cyclohexene-1-carbaldehyde; AEVLWICMAHGAMS-UHFFFAOYSA-N |
|
152.23 g/mol |
|
TCMBANKIN045065 |
Tirucallol |
(3S,5R,10S,13S,14S)-17-((S)-1,5-Dimethyl-hex-4-enyl)-4,4,10,13,14-pentamethyl-2,3,4,5,6,7,10,11,12,13,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-ol; (3S,5R,10S,13S,14S)-17-[(1S)-1,5-dimethylhex-4-enyl]-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; (3S,5R,10S,13S,14S)-4,4,10,13,14-pentamethyl-17-[(2S)-6-methylhept-5-en-2-yl]-2,3,5,6,7,11,12,15,16,17-decahydro-1H-cyclopenta[a]phenanthren-3-ol; AC1LAPT0; Tirucalla-8,24-dien-3 beta-ol |
|
426.72 |
|
TCMBANKIN046724 |
dioseptemloside C |
|
C42H68O13 |
781 |
C1([H])([H])C([H])([H])[C@@]2(C([H])([H])[H])C(=C([H])[C@@]([H])(C([H])(C([H])([H])[H])C([H])([H])[H])[C@]3([H])[C@]2([H])C([H])([H])C([H])([H])[C@](C([H])([H])[H])([C@@]([H])([C@]([H])(C([H])([H])[H]
)[C@]4(C([H])([H])C([H])([H])[C@@](C([H])([H])O[H])([H])C([H])([H])O4)O5)[C@]5([H])C6([H])[H])[C@]36[H])C([H])([H])[C@@]1([H])O[C@@]([H])(O[C@@]([H])(C([H])([H])O[H])[C@]7([H])O[C@@]([H])(O[C@]8([H])C
([H])([H])[H])[C@@]([H])(O[H])[C@@]([H])(O[H])[C@]8([H])O[H])[C@@]([H])(O[H])[C@@]7([H])O[H] |
TCMBANKIN058035 |
1H,3H-Pyrano(3,4-c)pyran-1-one, 5-ethenyl-6-(beta-D-glucopyranosyloxy)-4,4a,5,6-tetrahydro-, (4aS-(4aalpha,5beta,6alpha))-;sweroside |
(4aS,5R,6S)-6-[[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)-2-tetrahydropyranyl]oxy]-5-vinyl-4,4a,5,6-tetrahydro-3H-pyrano[5,4-c]pyran-1-one; ACon1_000233; (4aS,5R,6S)-5-ethenyl-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,4a,5,6-tetrahydro-3H-pyrano[5,4-c]pyran-1-one; 14215-86-2; (4aS,5R,6S)-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-methylol-tetrahydropyran-2-yl]oxy-5-vinyl-4,4a,5,6-tetrahydro-3H-pyrano[5,4-c]pyran-1-one; ACon0_001457; (4aS,5R,6S)-6-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydropyran-2-yl]oxy-5-vinyl-4,4a,5,6-tetrahydro-3H-pyrano[5,4-c]pyran-1-one; MEGxp0_000813 |
C16H22O9 |
358.34 |
C=CC1C2CCOC(=O)C2=COC1OC3C(C(C(C(O3)CO)O)O)O |
TCMBANKIN058060 |
gallic acid |
Spectrum4_001544; NSC-755825; 4CN-0954; KBio2_000822; NCGC00260064-01; KBio3_001168; CHEBI:30778; GTPL5549; D0Y3TZ; NCGC00091125-01; 632XD903SP; ARONIS23903; Spectrum5_000108; Jsp002851; T7419; Gallic acid, puriss., 98.0%; I14-9302; NCGC00091125-07; ZINC1504; 3,4,5-trihydroxybenzoic acid (ACD/Name 4.0); KBioGR_002008; AK-65266; pyrogallol-5-carboxylate; BRD-K77345217-001-01-9; Gallicum acidum; LNTHITQWFMADLM-UHFFFAOYSA-N; KBio2_003390; EBD679760; NCGC00091125-04; AJ-08037; Gallic acid; ZB000350; BG01502846; A808977; (?)-Gallic acid; WLN: QVR CQ DQ EQ; N1830; AC1NEVA5; SBB008781; 149-91-7; GALLIC ACID ANHYDROUS; Gallic acid [NF]; KS-00000IWM; CS-8191; LS-870; C01424; KS-00004784; CHEBI:16918; SPECTRUM210369; c0006; UNII-632XD903SP; ACMC-20aku5; CTK0H5618; BIDD:ER0374; AC1Q732X; NCGC00091125-02; F1908-0156; Oprea1_087792; CG0029; DSSTox_RID_75711; Kyselina 3,4,5-trihydroxybenzoova; 3-10-00-02070 (Beilstein Handbook Reference); RP23206; NSC36997; Gallic acid, certified reference material, TraceCERT(R); AI3-16412; CCG-38670; STK298718; Tox21_202515; bmse000389; AN-15162; AB00052697_03; SR-05000001537-2; NSC-36997; 1886-EP2374526A1; 5-Carboxybenzene-1,2,3-triol; KBio2_005958; SR-05000001537-3; NCGC00091125-05; KBio1_001347; Kyselina gallova [Czech]; KSC175M1R; KBioSS_000822; HMS2091A07; gallate; CPD-183; Spectrum3_000254; 78563C7D-0E2D-4766-A8EA-670A03C78FCF; gallic acid ; InChI=1/C7H6O5/c8-4-1-3(7(11)12)2-5(9)6(4)10/h1-2,8-10H,(H,11,12; GDE; SBI-0052184.P002; EINECS 205-749-9; CAS-149-91-7; Kyselina gallova; J3.617.291F; Benzoic acid, 3,4,5-trihydroxy-; BG00601456; DivK1c_006403; Benzoic acid,4,5-trihydroxy-; gallic acid for microelectronic industrial; BRN 2050274; Gallic acid tech.; NCGC00091125-03; Kyselina 3,4,5-trihydroxybenzoova [Czech]; Gallic acid, 97.5-102.5% (titration); gallicacid; 3,4,5-Trihydroxybenzoic acid, anhydrous; NSC674319; TR-020762; 3,4,5-tris(oxidanyl)benzoate; MCULE-1552954312; Gallic acid polymer; Pharmakon1600-00210369; BSPBio_001668; Tox21_111089; HMS1923K07; CCRIS 5523; BDBM50085536; NSC-674319; ST2404570; BB_SC-2795; AC-1206; 3,4,5-trihydroxy-Benzoic acid; Gallic Acid Hydrate; AC1L1934; RTR-020762; GALOP; Q-201146; SR-05000001537-1; DSSTox_CID_650; 3,4,5-Trihydroxybenzoic acid monohydrate, ACS, 98.0% min. 100g; 3,4,5-Trihydroxybenzoic acid ion; GALLICACID; s4603; CHEMBL288114; Gallic acid, tech.; NSC20103; 3,4,5-Trihydroxybenzoic acid; NSC755825; G0011; AB1002218; Gallic Acid, F; MolPort-000-881-260; NSC 674319; SPBio_000617; LNTHITQWFMADLM-UHFFFAOYSA-M; Spectrum_000342; PS-8710; SC-46383; FT-0626592; BBL009937; MFCD00002510; SpecPlus_000307; 3,4,5-trihydroxy-Benzoate; SCHEMBL15012; DSSTox_GSID_20650; ST083487; SR-05000001537; 3,5-Trihydroxybenzoic acid; 3,4,5-Trihydroxybenzoate, X; Tox21_111089_1; Gallic acid (Monohydrate or Anhydrous) (3,4,5-Trih; 3,4,5-Trihydroxybenzoic acid;; Z966690556; 3,4,5-Trihydroxybenzoate; SDCCGMLS-0066503.P001; Pyrogallol-5-carboxylic acid; BC200279; Spectrum2_000399; HY-N0523; HSDB 2117; AC1Q732Y; DTXSID0020650; 5-Trihydroxybenzoic acid; AKOS000119625; NSC 20103; Gallic acid, tech; 138-57-8; NSC-20103; AIDS-001349; gallate; CPD-183; Spectrum3_000254; KBio2_000822; Gallic acid monohydrate; AIDS-059239; KBio3_001168; Gallic acid, tech.; NSC20103; 3,4,5-Trihydroxybenzoic acid; InChI=1/C7H6O5/c8-4-1-3(7(11)12)2-5(9)6(4)10/h1-2,8-10H,(H,11,12; C01424; CHEBI:30778; EINECS 205-749-9; CHEBI:16918; NCGC00091125-01; c0006; J3.617.291F; SPECTRUM210369; Benzoic acid, 3,4,5-trihydroxy-; DivK1c_006403; NSC 674319; SPBio_000617; LNTHITQWFMADLM-UHFFFAOYSA-M; Spectrum_000342; Spectrum5_000108; NCGC00091125-02; BRN 2050274; Oprea1_087792; NCGC00091125-03; 3-10-00-02070 (Beilstein Handbook Reference); SpecPlus_000307; Kyselina 3,4,5-trihydroxybenzoova [Czech]; KBioGR_002008; AI3-16412; NSC674319; pyrogallol-5-carboxylate; 3,4,5-tris(oxidanyl)benzoate; AIDS001349; KBio2_003390; Gallic acid polymer; 1886-EP2374526A1; ZB000350; Gallic acid; BSPBio_001668; KBio2_005958; AIDS059239; CCRIS 5523; 3,4,5-Trihydroxybenzoate; SDCCGMLS-0066503.P001; Pyrogallol-5-carboxylic acid; A808977; 27645_RIEDEL; KBio1_001347; 398225_SIAL; Kyselina gallova [Czech]; WLN: QVR CQ DQ EQ; Spectrum2_000399; HSDB 2117; G7384_SIGMA; KBioSS_000822; GALOP; AC1NEVA5; SBB008781; 3,4,5-Trihydroxybenzoic acid monohydrate, ACS, 98.0% min. 100g; NSC 20103; 3,4,5-Trihydroxybenzoic acid ion; 149-91-7; 3,4,5-trihydroxybenzoic acid; Galllic acid |
C7H6O5 |
170.12 |
C1=C(C=C(C(=C1O)O)O)C(=O)O |
TCMBANKIN058317 |
Diphencyprone;2,3-diphenyl-2-cyclopropen-1-one |
Cyclopropenone, diphenyl- (8CI); CAS-886-38-4; ACMC-20al56; SCHEMBL105663; 2-Cyclopropen-1-one, 2,3-diphenyl- (9CI); SBB059194; MLS000758252; 2,3-diphenyl-cycloprop-2-en-1-one; NSC-57541; VZ22322; GEO-01240; MLS001424007; CHEMBL1373467; RTR-027871; CHEBI:53074; LS-58814; FT-0625256; Cyclopropenone, 2,3-diphenyl-; 4CH-019767; diphenylcycloprop-2-en-1-one; I7G14NW5EC; BBL007727; DSSTox_CID_26545; AKOS005257686; HMS2051I09; CCG-55613; InChI=1/C15H10O/c16-15-13(11-7-3-1-4-8-11)14(15)12-9-5-2-6-10-12/h1-10; TRA0065309; AX8125871; MFCD00001311; PS-4199; 2-Cyclopropen-1-one, 2,3-diphenyl-; 2,3-Diphenylcyclopropenone; D02XXT; Cyclopropenone,3-diphenyl-; 2,3-Diphenylcycloprop-2-en-1-one; KS-00001966; 2,3-Diphenyl-2-cyclopropen-1-one, 99% dry weight, may contain up to 5% water 1g; HMS2231A10; 2-Cyclopropen-1-one,3-diphenyl-; ST24038568; BG01516108; MolPort-001-762-066; AK159241; CPD000449319; AD-310/30361065; AC1L22HV; DPCP; NC00029; SAM001247027; SR-01000644630-1; UNII-I7G14NW5EC; Tox21_112322; SMR000449319; HMS547D03; Diphenylcyclopropenone, purum, >=98.0% (HPLC); OR22091; ZX-AT006360; DSSTox_GSID_46545; Diphenylcyclopropenone, 98%; Diphenylcyclopropenone; Diphencyprone; CTK3J1964; 1,2-Diphenylcyclopropen-3-one; HCIBTBXNLVOFER-UHFFFAOYSA-N; ST50319444; 886-38-4; Tox21_112322_1; KM2694; NSC 57541; EINECS 212-948-4; Epitope ID:113236; Cyclopropenone, diphenyl-; HMS3393I09; MCULE-6674594079; NCGC00166113-01; NSC57541; I14-48040; KB-87826; 2,3-Diphenylcycloprop-2-enone; DSSTox_RID_81708; NCGC00166113-02; Maybridge1_002005; W-200519; 2,3-diphenyl cyclopropenone; 2,3-Diphenyl-2-cyclopropen-1-one; STK289679; DB12173; DTXSID2046545; NCGC00166113-04 |
C15H10O |
206.24 g/mol |
C1=CC=C(C=C1)C2=C(C2=O)C3=CC=CC=C3 |
TCMBANKIN059521 |
B- pinene;pinene;T-pinene;(-)-nopinene;beta-pinene;bicyclo[3.1.1]heptane,6,6-dimethyl-2-methylene-,(1s);1-β-pinene;()-beta-Pinene;(-)- β- pinene;laevo- β- Pinene |
|
C10H16 |
136.23 g/mol |
CC1(C2CCC(=C)C1C2)C |
TCMBANKIN059522 |
(1R)-()-Nopinone |
|
C9H14O |
138.21 g/mol |
CC1(C2CCC(=O)C1C2)C |
TCMBANKIN059920 |
o-methylacetophenone |
|
C9H10O |
134.17 g/mol |
CC1=CC=CC=C1C(=O)C |
TCMBANKIN059922 |
o-cresol;Phenol, 2- methyl-;2-hydroxytoluene |
|
C7H8O |
108.14 g/mol |
CC1=CC=CC=C1O |
TCMBANKIN059974 |
alpha-phellandrene |
|
C10H16 |
136.23 |
CC1=CCC(C=C1)C(C)C |
TCMBANKIN059982 |
d-limonene |
|
C10H16 |
136.23 g/mol |
CC1=CCC(CC1)C(=C)C |
TCMBANKIN060220 |
(23s,25r)-23-hydroxyspirost-5-en-3β-yl-o-α-l-rhamnopyranosyl-(1→2)-o-[β-d-glucopyra-nosyl-(1→6)]-β-d-glucopyranoside |
|
C45H72O18 |
|
CC1C(C(C(C(O1)OC2C(C(OC(C2OC3C(C(C(C(O3)C)O)O)O)OC4CCC5(C6CCC7(C(C6CC=C5C4)CC8C7(C(C9(O8)CCC(CO9)(C)O)C)O)C)C)CO)O)O)O)O |
TCMBANKIN060353 |
trigofoenoside d |
|
C51H84O23 |
1065.2 g/mol |
CC1C2C(CC3C2(CCC4C3CC=C5C4(CCC(C5)OC6C(C(C(C(O6)CO)O)OC7C(C(C(C(O7)CO)O)O)O)OC8C(C(C(C(O8)C)O)O)O)C)C)OC1(CCC(C)COC9C(C(C(C(O9)CO)O)O)O)O |
TCMBANKIN060354 |
trigonelloside c |
|
C51H84O22 |
1049.2 g/mol |
CC1C2C(CC3C2(CCC4C3CC=C5C4(CCC(C5)OC6C(C(C(C(O6)CO)OC7C(C(C(C(O7)C)O)O)O)O)OC8C(C(C(C(O8)C)O)O)O)C)C)OC1(CCC(C)COC9C(C(C(C(O9)CO)O)O)O)O |
TCMBANKIN060355 |
methylprotodioscin |
|
C52H86O22 |
1063.23 |
CC1C2C(CC3C2(CCC4C3CC=C5C4(CCC(C5)OC6C(C(C(C(O6)CO)OC7C(C(C(C(O7)C)O)O)O)O)OC8C(C(C(C(O8)C)O)O)O)C)C)OC1(CCC(C)COC9C(C(C(C(O9)CO)O)O)O)OC |
TCMBANKIN060490 |
Dioscorea septemloba Thunb A |
|
C27H42O3 |
|
CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)O)C)C)C)OC1 |
TCMBANKIN060491 |
EINECS 213-897-0 |
|
C29H44O4 |
456.7 g/mol |
CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)OC(=O)C)C)C)C)OC1 |
TCMBANKIN060492 |
diosgenin-3-O-β-D-glucopyranoside) |
|
C33H52O8 |
576.76 |
CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)OC7C(C(C(C(O7)CO)O)O)O)C)C)C)OC1 |
TCMBANKIN060497 |
dioscin |
|
C45H72O16 |
869.04 |
CC1CCC2(C(C3C(O2)CC4C3(CCC5C4CC=C6C5(CCC(C6)OC7C(C(C(C(O7)CO)OC8C(C(C(C(O8)C)O)O)O)O)OC9C(C(C(C(O9)C)O)O)O)C)C)C)OC1 |
TCMBANKIN060539 |
α-amyrone |
|
C30H48O |
424.7 |
CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(=O)C5(C)C)C)C)C2C1C)C)C |
TCMBANKIN060540 |
Boswellic acid;β一 boswellic acid;β-boswellicacid |
|
C30H48O3 |
456.7 |
CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C(=O)O)O)C)C)C2C1C)C)C |
TCMBANKIN060544 |
alpha-amyrin |
|
C30H50O |
426.72 g/mol |
CC1CCC2(CCC3(C(=CCC4C3(CCC5C4(CCC(C5(C)C)O)C)C)C2C1C)C)C |
TCMBANKIN060679 |
stigmasterol |
|
C29H48O |
412.7 g/mol |
CCC(C=CC(C)C1CCC2C1(CCC3C2CC=C4C3(CCC(C4)O)C)C)C(C)C |
TCMBANKIN061288 |
donasine |
|
C11H14N2 |
174.24 g/mol |
CN(C)CC1=CNC2=CC=CC=C21 |